125 related articles for article (PubMed ID: 34510668)
1. COVID-Q: Validation of the first COVID-19 questionnaire based on patient-rated symptom gravity.
Spinato G; Fabbris C; Conte F; Menegaldo A; Franz L; Gaudioso P; Cinetto F; Agostini C; Costantini G; Boscolo-Rizzo P
Int J Clin Pract; 2021 Dec; 75(12):e14829. PubMed ID: 34510668
[TBL] [Abstract][Full Text] [Related]
2. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
[TBL] [Abstract][Full Text] [Related]
3. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
4. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Factors Causing False-Negative Real-Time Polymerase Chain Reaction Results in Oropharyngeal and Nasopharyngeal Swabs of Patients With COVID-19.
İşlek A; Balcı MK
Ear Nose Throat J; 2022 May; 101(4):234-238. PubMed ID: 33601901
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. The importance of early detection of ENT symptoms in mild-to-moderate COVID-19.
Spinato G; Costantini G; Fabbris C; Menegaldo A; Mularoni F; Gaudioso P; Mantovani M; Borsetto D; Vijendren A; Da Mosto MC; Boscolo-Rizzo P
Acta Otorhinolaryngol Ital; 2021 Apr; 41(2):101-107. PubMed ID: 34028454
[TBL] [Abstract][Full Text] [Related]
8. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.
Yan CH; Faraji F; Prajapati DP; Boone CE; DeConde AS
Int Forum Allergy Rhinol; 2020 Jul; 10(7):806-813. PubMed ID: 32279441
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
[TBL] [Abstract][Full Text] [Related]
10. New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.
Vaira LA; De Vito A; Lechien JR; Chiesa-Estomba CM; Mayo-Yàñez M; Calvo-Henrìquez C; Saussez S; Madeddu G; Babudieri S; Boscolo-Rizzo P; Hopkins C; De Riu G
Laryngoscope; 2022 Feb; 132(2):419-421. PubMed ID: 34812498
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
Corsini Campioli C; Cano Cevallos E; Assi M; Patel R; Binnicker MJ; O'Horo JC
J Clin Virol; 2020 Sep; 130():104577. PubMed ID: 32777762
[TBL] [Abstract][Full Text] [Related]
12. Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey.
Qin S; Li Y; Wang L; Zhao X; Ma X; Gao GF
Emerg Microbes Infect; 2023 Dec; 12(2):2258232. PubMed ID: 37691586
[TBL] [Abstract][Full Text] [Related]
13. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
14. [Anosmia and ageusia as primary symptoms of COVID-19].
Haldrup M; Johansen MI; Fjaeldstad AW
Ugeskr Laeger; 2020 Apr; 182(18):. PubMed ID: 32400371
[TBL] [Abstract][Full Text] [Related]
15. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
Lee Y; Min P; Lee S; Kim SW
J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of work-related COVID-19 in Croatian healthcare workers: a preliminary report.
Žaja R; Kerner I; Macan J; Milošević M
Arh Hig Rada Toksikol; 2021 Mar; 72(1):36-41. PubMed ID: 33787182
[TBL] [Abstract][Full Text] [Related]
18. Symptom profiles and their risk factors in patients with post-COVID-19 condition: a Dutch longitudinal cohort study.
van Zon SKR; Ballering AV; Brouwer S; Rosmalen JGM;
Eur J Public Health; 2023 Dec; 33(6):1163-1170. PubMed ID: 37608757
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-Induced Anosmia and Ageusia Are Associated With Younger Age and Lower Blood Eosinophil Counts.
Sehanobish E; Barbi M; Fong V; Kravitz M; Sanchez Tejera D; Asad M; Matsumura C; Ferastraoaru D; O'Neill M; Karagic M; Akbar N; Bottalico DM; Patel V; Peshansky A; Rangareddy M; Hudes G; Kim M; Eisenberg R; Nath A; Smith BR; Ow TJ; Jerschow E
Am J Rhinol Allergy; 2021 Nov; 35(6):830-839. PubMed ID: 33813917
[TBL] [Abstract][Full Text] [Related]
20. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.
Trachootham D; Thongyen S; Lam-Ubol A; Chotechuang N; Pongpirul W; Prasithsirikul W
Int J Infect Dis; 2021 May; 106():329-337. PubMed ID: 33819604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
